Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cellline development into one simultaneous process.

$341.7M

Market Cap • 12/20/2024

2011

(13 years)
Founded

2021

(3 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Vancouver

Headquarters • Washington